Status:

RECRUITING

Wavelength Intervention for Nearsighted Kids

Lead Sponsor:

University of Alabama at Birmingham

Collaborating Sponsors:

National Eye Institute (NEI)

Conditions:

Myopia

Eligibility:

All Genders

7-12 years

Phase:

NA

Brief Summary

The goal of this clinical trial is to learn if daily brief periods of specialized soft contact lens wear work to slow the progression of nearsightedness in children. Additionally, the study will learn...

Detailed Description

Myopia (nearsightedness) is a major public health concern. The prevalence of myopia continues to rise globally, including in the United States. Myopia develops when the eye grows excessively long for ...

Eligibility Criteria

Inclusion

  • Spherical component of refractive error in primary meridian between -0.75 and -5.00 D
  • Less than 1.00 D of astigmatism or anisometropia
  • History of soft contact lens wear for at least a week
  • Best-corrected visual acuity of 20/25 (+0.10 logMAR) or better in each eye
  • Willingness to wear the lenses for a minimum of 10 hours/day, at least six days a week for the duration of the study

Exclusion

  • Subjects receiving myopia control treatments within the past six months
  • History of premature (less than 3.3 lb) or preterm birth (earlier than 30 weeks)
  • Current history of using systemic or ocular medications (including artificial tears) that may affect contact lens wear, tear film health, refractive state, pupillary response or accommodative function
  • History of ocular or systemic diseases, including those that may affect refractive development
  • Known allergy to fluorescein, benoxinate, proparacaine, or tropicamide
  • Contact lens contraindications (e.g., giant papillary keratoconjunctivitis)
  • Corneal disorders (e.g., hypoesthesia, keratoconus)
  • Strabismus at distance or near with distance glasses or contact lenses
  • Subjects exhibiting poor personal hygiene that may affect the compliance of contact lens wear.

Key Trial Info

Start Date :

April 10 2025

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

July 31 2027

Estimated Enrollment :

80 Patients enrolled

Trial Details

Trial ID

NCT06598423

Start Date

April 10 2025

End Date

July 31 2027

Last Update

October 8 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

University of Alabama at Birmingham School of Optometry

Birmingham, Alabama, United States, 35233

Wavelength Intervention for Nearsighted Kids | DecenTrialz